Laboratory Billing Under Scrutiny: New Audit Trends and What to Watch in 2027

When reimbursement is under pressure, preventable denials, payment delays, and recoupments become harder for laboratories to absorb. For leaders responsible for laboratory and pathology services, understanding where billing practices leave revenue exposed is essential to making informed financial and operational decisions.

Join Ann Lambrix, Executive Director of RCM Consulting at Lighthouse Lab Services, for a practical review of recent laboratory billing audit trends and the issues laboratories should watch in 2027 and beyond.

Drawing on our work with laboratories and pathology practices, this session will connect payer scrutiny, reimbursement developments, and coding concerns with practical opportunities to strengthen billing compliance and protect revenue.

During this session, attendees will explore:

• Audit and Enforcement Trends: Emerging areas of focus for CMS and commercial payers, informed by Lighthouse’s 2026 audit observations and recent regulatory announcements.
• PAMA and the CLFS: The outlook for PAMA-related Clinical Laboratory Fee Schedule reductions and their implications for revenue planning.
• Laboratory and Pathology Coding Concerns: Recent coding, documentation, and medical necessity issues that warrant closer review.
• Proactive Revenue Protection: How routine coding and billing audits can help identify errors, reduce avoidable denials and recoupment risk, and support more consistent reimbursement.

Who should attend?

This webinar is designed for laboratory owners and managers, pathologists, hospital administrators overseeing laboratory and pathology services, revenue cycle managers and billing specialists, and related financial and operational decision-makers.